AMG:ETR
Amgen
419,70 €
arrow_downward
-1,68%(-7,15) 1d
17 de nov., 13:22:23 GMT+1 · EUR
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a AMG...
Obre
424,25 €
Alt
424,25 €
Baix
418,60 €
Capitalització borsà ria
250,07Â kM
Volum mitjÃ
532,00
Volum
50,00
Alt 52 setmanes
438,75 €
Baix 52 setmanes
267,60 €
Nombre d'empleats
32Â k
Obre
424,25 €
Alt
424,25 €
Baix
418,60 €
Capitalització borsà ria
250,07Â kM
Volum mitjÃ
532,00
Volum
50,00
Alt 52 setmanes
438,75 €
Baix 52 setmanes
267,60 €
Nombre d'empleats
32Â k
NotÃcies
De fonts web i partners de notÃcies
Investor's Business Daily
·
fa 19 hores
Dow Jones Biotech Giant Amgen In Buy Zone Amid Ongoing Stock Market Weakness
Yahoo Finance
·
fa 1 dia
Is Amgen Stock Still Telling Investors The Same Thing?
Perfil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Sobre Amgen
Conseller delegatRobert A. Bradway
Empleats31,5Â k
Fundació1980
Seu principalThousand Oaks, Califòrnia, Estats Units d'Amèrica
SectorHealth Care
Sector-
Lloc webamgen.com